Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily Versus Alternate-Day Oral Iron Therapy for Anemia Correction in Second-Trimester Pregnant Patients
NCT07657455Not yet recruiting
- Sponsor
- PAF Hospital Islamabad
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by PAF Hospital Islamabad. Primary endpoint: Change in hemoglobin from baseline at 4 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07657455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657455.